Calls for expanded genetic testing funding While the MBS item covering three conditions is welcome, experts say greater funding would boost access for more conditions and counselling.
Cystic fibrosis medication expanded on PBS Doctors can soon prescribe subsidised Trikafta to children earlier, in a ‘lifechanging’ move set to save families $250,000 each year.
Cystic fibrosis drug listed on PBS While the announcement was welcomed, some have questioned the seven month delay between approval and listing.
Access to cystic fibrosis medication expanded Children aged 12–24 months with a rare form of the genetic disorder will soon be eligible to receive subsidised medication, saving their families up to $300,000 per year.
New drugs listed on the PBS for rheumatoid arthritis, cystic fibrosis and ADHD Vital drugs for rheumatoid arthritis, cystic fibrosis and attention deficit hyperactivity disorder will now be more accessible for patients.
‘She’s never had to think about what she’ll do in the future’: Patients hail listing of CF drug News that a long-sought cystic fibrosis drug will be listed on the PBS has given many Australians a sense of hope.
Stem cell research offers hope for people with cystic fibrosis University of Adelaide research shows cell transplant therapy has the potential to prevent onset or halt lung disease in cystic fibrosis patients.